Tag - RetroSense

Life sciences sector is heartbeat of Michigan innovation

When you think of medical innovation, you may think of San Diego, Boston or the San Francisco Bay area. But entrepreneurial activity in medical innovation has been flourishing across Michigan and top talent, investors and leading life science corporations across the world have taken notice.

Fred Molnar is vice president of entrepreneurship and innovation at the Michigan Economic Development Corp.

For instance, this year an Ann Arbor-based biotech startup, RetroSense Therapeutics, was acquired by leading global pharmaceutical company Allergan plc for […]

What Allergan Is Buying and Shedding to Gain a Better Position (Retrosense Therapeutics)

When Actavis Plc. acquired Allergan Inc. in March 2015, the company changed its name from Actavis Plc. to Allergan Plc (AGN)…In September 2016, Allergan announced the acquisition of Retrosense Therapeutics, a gene therapy company, in order to strengthen its Eye Care pipeline by Retrosense’s first-in-class technology RST-001 for the potential treatment of retinitis pigmentosa. Read more >>

Allergan Acquires Gene Therapy Company RetroSense Therapeutics Adding First-In-Class Technology to Company’s Innovative Eye Care Pipeline

llergan plc (NYSE: AGN), a leading global pharmaceutical company, and RetroSense Therapeutics LLC, a private, clinical-stage biotechnology company focused on novel gene therapy approaches to restore vision in patients suffering from blindness, today announced that Allergan has acquired substantially all of the assets of RetroSense in an all-cash transaction. Under the terms of the transaction, Allergan has paid RetroSense a $60 million upfront payment, and has agreed to potential regulatory and commercialization milestone payments related to its lead […]